Ajanta Pharma has received final USFDA approval for Entacapone tablets to market the same in USA. It is a bioequivalent generic version of Comtan tablets. The company will be launching the product shortly in 200mg strength tablets. Entacapone tablets is part of an ever growing portfolio of products that Ajanta has developed for the US market. In total, Ajanta has 35 Abbreviated New Drug Application (ANDA) of which it has final approvals for 20 ANDAs; tentative approvals for 2 ANDA; and 13 ANDAs are under review with US FDA.
Company Profile : Ajanta Pharma Ltd